Leucovorin as a prodrug.

[1]  J. Doroshow,et al.  Pharmacokinetics and toxicity of continuous infusion (6S)-folinic acid and bolus 5-fluorouracil in patients with advanced cancer. , 1992, Cancer research.

[2]  J. C. Schmitz,et al.  Pharmacokinetics of leucovorin metabolites in human plasma as a function of dose administered orally and intravenously. , 1991, Journal of the National Cancer Institute.

[3]  D. Priest,et al.  Human red blood cell-mediated metabolism of leucovorin [(R,S)5-formyltetrahydrofolate]. , 1991, Archives of biochemistry and biophysics.

[4]  R. Schilsky,et al.  Clinical pharmacokinetics of high-dose leucovorin calcium after intravenous and oral administration. , 1990, Journal of the National Cancer Institute.

[5]  P. Houghton,et al.  Relationship between dose rate of [6RS]Leucovorin administration, plasma concentrations of reduced folates, and pools of 5,10-methylenetetrahydrofolates and tetrahydrofolates in human colon adenocarcinoma xenografts. , 1990, Cancer research.

[6]  J. Zittoun,et al.  Pharmacokinetics of (-)-folinic acid after oral and intravenous administration of the racemate. , 1989, British journal of clinical pharmacology.

[7]  R. Ferone,et al.  Clinical experience with leucovorin and 5‐fluorouracil , 1989, Cancer.

[8]  D. Adelstein,et al.  Efficacy of high‐dose oral leucovorin and 5‐fluorouracil in advanced colorectal carcinoma. Plasma and tissue pharmacokinetics , 1989, Cancer.

[9]  P. Houghton,et al.  Comparison of the conversion of 5-formyltetrahydrofolate and 5-methyltetrahydrofolate to 5,10-methylenetetrahydrofolates and tetrahydrofolates in human colon tumors. , 1989, Cancer communications.

[10]  N. Petrelli,et al.  Plasma and tumor tissue pharmacology of high-dose intravenous leucovorin calcium in combination with fluorouracil in patients with advanced colorectal carcinoma. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  D. Santi,et al.  Cloning, sequencing, and expression of the Lactobacillus casei thymidylate synthase gene. , 1988, DNA.

[12]  J. Bertino,et al.  Effects of 5-methyltetrahydrofolate on the activity of fluoropyrimidines against human leukemia (CCRF-CEM) cells. , 1987, Biochemical pharmacology.

[13]  R. Mackenzie,et al.  Human liver methenyltetrahydrofolate synthetase: improved purification and increased affinity for folate polyglutamate substrates. , 1987, Biochimica et biophysica acta.

[14]  Stokstad El,et al.  Absorption kinetics of orally administered leucovorin calcium. , 1987, NCI monographs : a publication of the National Cancer Institute.

[15]  D. Priest,et al.  Tissue folate polyglutamate chain length determination by electrophoresis as thymidylate synthase-fluorodeoxyuridylate ternary complexes. , 1986, Methods in enzymology.

[16]  R. Matthews Methylenetetrahydrofolate reductase from pig liver. , 1986, Methods in enzymology.

[17]  W. T. Wynn,et al.  Pharmacokinetics of the diastereoisomers of leucovorin after intravenous and oral administration to normal subjects. , 1984, Cancer research.

[18]  S. Hopkins,et al.  5,10-Methenyltetrahydrofolate synthetase. Purification and properties of the enzyme from rabbit liver. , 1984, The Journal of biological chemistry.

[19]  S. Benkovic,et al.  Folates and pterins , 1984 .

[20]  P. Houghton,et al.  The effect of derivatives of folic acid on the fluorodeoxyuridylate-thymidylate synthetase covalent complex in human colon xenografts. , 1982, European journal of cancer & clinical oncology.

[21]  J. Laskin,et al.  Effect of excess folates and deoxyinosine on the activity and site of action of 5-fluorouracil. , 1981, Cancer research.

[22]  K. Danenberg,et al.  Effect of 5, 10-methylenetetrahydrofolate on the dissociation of 5-fluoro-2'-deoxyuridylate from thymidylate synthetase: evidence for an ordered mechanism. , 1978, Biochemistry.

[23]  D. Santi,et al.  Cytotoxicity of 5-fluoro-2'-deoxyuridine: requirement for reduced folate cofactors and antagonism by methotrexate. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[24]  B. Cooper,et al.  Intestinal Conversion of Folinic Acid to 5‐Methyltetrahydrofolate in Man , 1972, British journal of haematology.

[25]  F. M. Huennekens,et al.  Thymidylate synthetase from amethopterin-resistant Lactobacillus casei. , 1971, Biochemistry.

[26]  F. M. Huennekens,et al.  [50] N10-formyltetrahydrofolic deacylase: N10-formyltetrahydrofolate + H2O → formate + tetrahydrofolate , 1963 .